ID: ALA4745800

Max Phase: Preclinical

Molecular Formula: C38H42N2O7

Molecular Weight: 638.76

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1ccc2cc1Oc1ccc(cc1)C[C@H]1c3cc(c(OC)cc3CCN1C)Oc1c(OC)c(OC)cc3c1[C@H](C2)N(OC)CC3

Standard InChI:  InChI=1S/C38H42N2O7/c1-39-15-13-25-20-32(42-3)34-22-28(25)29(39)17-23-7-10-27(11-8-23)46-33-19-24(9-12-31(33)41-2)18-30-36-26(14-16-40(30)45-6)21-35(43-4)37(44-5)38(36)47-34/h7-12,19-22,29-30H,13-18H2,1-6H3/t29-,30-/m0/s1

Standard InChI Key:  ISBSKKSDTPRNKX-KYJUHHDHSA-N

Associated Targets(Human)

MRC5 9203 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human coronavirus OC43 66 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 638.76Molecular Weight (Monoisotopic): 638.2992AlogP: 7.09#Rotatable Bonds: 5
Polar Surface Area: 71.09Molecular Species: NEUTRALHBA: 9HBD: 0
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.19CX LogP: 6.09CX LogD: 5.24
Aromatic Rings: 4Heavy Atoms: 47QED Weighted: 0.23Np Likeness Score: 1.65

References

1. Choudhry N,Zhao X,Xu D,Zanin M,Chen W,Yang Z,Chen J.  (2020)  Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).,  63  (22.0): [PMID:32845145] [10.1021/acs.jmedchem.0c00626]

Source